Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 4Phase 3 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 32Colonic Neoplasms 20Rectal Neoplasms 11Carcinoma, Hepatocellular 7Neoplasm Metastasis 5Stomach Neoplasms 2Neoplastic Cells, Circulating 2Neoplasms 2Liver Neoplasms 2Recurrence 1Peritoneal Neoplasms 1Pathologic Complete Response 1Pancreatic Neoplasms 1Oligometastatic Gastric Adenocarcinoma 1Neuroendocrine Tumors 1Neoplasms, Second Primary 1Neoplasm, Residual 1Neoplasm Recurrence, Local 1Margins of Excision 1Locally Advanced Rectal Cancer 1Gastro-enteropancreatic neuroendocrine tumor 1Gallbladder Neoplasms 1Cholangiocarcinoma 1Biliary Tract Neoplasms 1

Interventions

Paclitaxel 20Gemcitabine 16Dexamethasone 16Bevacizumab 16Docetaxel 15Oxaliplatin 14Cyclophosphamide 13Carboplatin 12Capecitabine 12Sorafenib 11Fluorouracil 11Leucovorin 10Cisplatin 10pembrolizumab 9Pemetrexed 9Epoetin Alfa 9venetoclax 8Prednisone 8Fentanyl 8Drug Therapy 8Doxorubicin 8atezolizumab 7Rivaroxaban 7Rituximab 7Darbepoetin alfa 7Anastrozole 7Panitumumab 6Ondansetron 6Morphine 6Irinotecan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms × Folfox protocol × Clear all
NCT02967289 2025-11-17

IROCAS

UNICANCER

Phase 3 Completed
792 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasms

NCT00364013 2022-11-07

PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy

Amgen

Phase 3 Completed
1,183 enrolled 18 charts
Gastrointestinal

Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡